The initial biopsy Gleason score as a predictive marker for docetaxel survival benefit in patients with prostate cancer: Data from the TAX 327 study

被引：4
|
作者：
van Soest, Robert
de Morree, Ellen
Shen, Liji
Tannock, Ian
Eisenberger, Mario A.
De Wit, Ronald
机构：
[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[2] Sanofi, Malvern, PA USA
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.44
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
44
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Decipher mRNA score for prediction of survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for advanced prostate cancer (PC): An ancillary study of the STAMPEDE docetaxel trials
    Grist, E.
    Dutey-Magni, P.
    Mendes, L.
    Parry, M. A.
    Sachdeva, A.
    Proudfoot, J.
    Hamid, A. A.
    Amos, C. L.
    Cross, W.
    Gillessen, S.
    Berney, D. M.
    Sydes, M. R.
    Parmar, M. K.
    Feng, F.
    Clarke, N.
    Davicioni, E.
    Sweeney, C.
    James, N. D.
    Brown, L. C.
    Attard, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S961 - S962
  • [22] PROSTATE CANCER PATIENTS WITH METABOLIC SYNDROME SHOWED LOW GRADE GLEASON SCORE WHEN DIAGNOSED ON BIOPSY
    Kim, Dong Suk
    Jeon, Kyung Pil
    Lee, Seo Yeon
    Kee, Joong Sik
    Lee, Seung Ryeol
    Jeong, Tae Yoong
    JOURNAL OF UROLOGY, 2012, 187 (04): : E588 - E588
  • [23] Prostate Cancer in Patients with Metabolic Syndrome Is Associated with Low Grade Gleason Score When Diagnosed on Biopsy
    Jeon, Kyoung Pil
    Jeong, Tae Yoong
    Lee, Seo Yeon
    Hwang, Sang Won
    Shin, Joong Hui
    Kim, Dong Suk
    KOREAN JOURNAL OF UROLOGY, 2012, 53 (09) : 593 - 597
  • [24] The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer
    Tohi, Yoichiro
    Matsuda, Iori
    Fujiwara, Kengo
    Harada, Satoshi
    Ito, Ayako
    Yamasaki, Mari
    Miyauchi, Yasuyuki
    Matsuoka, Yuki
    Kato, Takuma
    Taoka, Rikiya
    Tsunemori, Hiroyuki
    Ueda, Nobufumi
    Sugimoto, Mikio
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (03)
  • [25] THE IMPACT OF GLEASON SCORE FROM THE BIOPSY AND FROM THE RADICAL PROSTATE- CTOMY ON THE BIOCHEMICAL PROGRESSION- FREE SURVIVAL
    Lazarov, Boyan
    Ganev, Tosho
    JOURNAL OF IMAB, 2022, 28 (04): : 4720 - 4723
  • [26] Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
    Rapiti, Elisabetta
    Schaffar, Robin
    Iselin, Christophe
    Miralbell, Raymond
    Pelte, Marie-Francoise
    Weber, Damien
    Zanetti, Roberto
    Neyroud-Caspar, Isabelle
    Bouchardy, Christine
    BMC UROLOGY, 2013, 13
  • [27] Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
    Elisabetta Rapiti
    Robin Schaffar
    Christophe Iselin
    Raymond Miralbell
    Marie-Françoise Pelte
    Damien Weber
    Roberto Zanetti
    Isabelle Neyroud-Caspar
    Christine Bouchardy
    BMC Urology, 13
  • [28] Differences in contemporary biopsy Gleason score distribution in men diagnosed with prostate cancer from China and Canada
    Dong, L.
    Woon, D. T. S.
    Mari, A.
    Kuk, C.
    Erlich, A. F.
    Ma, Z.
    Shi, O.
    Qian, H.
    Dong, B.
    Nesbitt, M.
    Carlsson, S. V.
    Kulkarni, G. S.
    Hamilton, R.
    Finelli, A.
    Fleshner, N.
    Liu, Q.
    Van der Kwast, T. H.
    Xue, W.
    Zlotta, A. R.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 20 - 20
  • [29] Biopsy undergrading in men with Gleason score6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam
    Alberts, Arnout R.
    Bokhorst, Leonard P.
    Kweldam, Charlotte F.
    Schoots, Ivo G.
    van der Kwast, Theo H.
    van Leenders, Geert J.
    Roobol, Monique J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (04) : 281 - 286
  • [30] CCP Score Stratifies Risk for Prostate Cancer Patients at Biopsy: Initial Commercial Results
    Crawford, E.
    Shore, N.
    Scardino, P.
    Davis, J.
    Tward, J. D.
    Moyes, K.
    Fitzgerald, L.
    Stone, S.
    Brawer, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S433 - S433
12345